rs146886839

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_004946.3(DOCK2):​c.5425A>G​(p.Thr1809Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000176 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000090 ( 0 hom. )

Consequence

DOCK2
NM_004946.3 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.04

Publications

0 publications found
Variant links:
Genes affected
DOCK2 (HGNC:2988): (dedicator of cytokinesis 2) The protein encoded by this gene belongs to the CDM protein family. It is specifically expressed in hematopoietic cells and is predominantly expressed in peripheral blood leukocytes. The protein is involved in remodeling of the actin cytoskeleton required for lymphocyte migration in response to chemokine signaling. It activates members of the Rho family of GTPases, for example RAC1 and RAC2, by acting as a guanine nucleotide exchange factor (GEF) to exchange bound GDP for free GTP. Mutations in this gene result in immunodeficiency 40 (IMD40), a combined form of immunodeficiency that affects T cell number and function, also with variable defects in B cell and NK cell function. [provided by RefSeq, May 2018]
DOCK2 Gene-Disease associations (from GenCC):
  • DOCK2 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006100863).
BP6
Variant 5-170081979-A-G is Benign according to our data. Variant chr5-170081979-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 542639.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.001 (153/152294) while in subpopulation AFR AF = 0.00347 (144/41554). AF 95% confidence interval is 0.003. There are 0 homozygotes in GnomAd4. There are 77 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOCK2NM_004946.3 linkc.5425A>G p.Thr1809Ala missense_variant Exon 51 of 52 ENST00000520908.7 NP_004937.1
DOCK2NR_156756.1 linkn.5528A>G non_coding_transcript_exon_variant Exon 52 of 53

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOCK2ENST00000520908.7 linkc.5425A>G p.Thr1809Ala missense_variant Exon 51 of 52 2 NM_004946.3 ENSP00000429283.3

Frequencies

GnomAD3 genomes
AF:
0.00101
AC:
153
AN:
152176
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00348
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000267
AC:
67
AN:
250796
AF XY:
0.000207
show subpopulations
Gnomad AFR exome
AF:
0.00400
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000896
AC:
131
AN:
1461606
Hom.:
0
Cov.:
34
AF XY:
0.0000839
AC XY:
61
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.00344
AC:
115
AN:
33478
American (AMR)
AF:
0.0000447
AC:
2
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111840
Other (OTH)
AF:
0.000215
AC:
13
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00100
AC:
153
AN:
152294
Hom.:
0
Cov.:
31
AF XY:
0.00103
AC XY:
77
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00347
AC:
144
AN:
41554
American (AMR)
AF:
0.000457
AC:
7
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000377
Hom.:
0
Bravo
AF:
0.00132
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000296
AC:
36
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

DOCK2-related disorder Uncertain:1
Jun 16, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The DOCK2 c.5425A>G variant is predicted to result in the amino acid substitution p.Thr1809Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.38% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-169508983-A-G). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

DOCK2 deficiency Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.076
T;T
Eigen
Benign
0.026
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.64
.;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0061
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;L
PhyloP100
4.0
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.77
N;.
REVEL
Benign
0.053
Sift
Uncertain
0.010
D;.
Sift4G
Benign
0.13
T;.
Polyphen
0.24
B;B
Vest4
0.23
MVP
0.59
MPC
0.71
ClinPred
0.058
T
GERP RS
3.7
Varity_R
0.092
gMVP
0.36
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146886839; hg19: chr5-169508983; COSMIC: COSV106084497; API